Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon launches new warehouse complex in Volgograd region

10/6/23 OZON

Sistema will build a skiing complex in Sheregesh

10/6/23 AFKS

Etalon completes occupancy of Silver Fountain Residential Complex

10/6/23 ETLN

LSR will improve the beach strip near the Volna sanatorium in Sochi

10/6/23 LSRG

Chizhik intends to become a leader in the hard discounter segment

10/6/23 FIVE

X5 Retail Group will start testing small format stores

10/6/23 FIVE

Board of Directors of Avangard Bank recommended that dividends be paid for 9 months 2023

10/6/23 AVAN

Rusolovo received the first tonne of copper concentrate at Pravourmyskoye

10/6/23 ROLO

Rusagro bought Biotechnologies elevator

10/6/23 RAGR

Yandex taught neural network to retell videos

10/6/23 YNDX